By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Sanofi (France) 

Parent Company
174/180 Avenue de France
Paris  Cedex  75013  France
Phone: 33-1-53-77-4000 Fax:



Company News
Sanofi (SNY)'s Lixilan Hits Phase III Goal 7/29/2015 6:00:37 AM
Sanofi (SNY) and Regeneron (REGN) Ink $2.2 Billion Immuno-Oncology, PD-1 Inhibitor Deal 7/28/2015 5:48:51 AM
Sanofi (SNY), Regeneron (REGN)’s $15,000-a-Year Heart Drug May Trigger New Cost Concerns 7/27/2015 7:21:29 AM
AstraZeneca PLC (AZN) Divests Yet Another Drug, This Time to Sanofi (SNY) for $300 Million 7/27/2015 6:11:08 AM
FDA Approves Cholesterol Drug Praluent From Regeneron (REGN), Sanofi (SNY) 7/24/2015 2:07:33 PM
Regeneron (REGN), Sanofi (SNY)'s Big New Cholesterol Drug Praluent Wins European Green Light 7/24/2015 6:08:02 AM
Amgen (AMGN) Beats Sanofi (SNY)/Regeneron (REGN) to European Market for Cholesterol Drug, but Race is Still on for U.S. Market 7/21/2015 6:07:39 AM
Sanofi (SNY) Trims Business Units From Seven to Five to Drive Growth 7/15/2015 7:48:26 AM
As Government Money Dwindles, Sanofi (SAN.PA) and University of Texas Team Up on Funding 7/10/2015 6:35:52 AM
Regeneron (REGN) And Sanofi (SAN.PA) Announce Phase III Results Showing LDL-C Reductions Of More Than 60 Percent In Japanese Patients Treated With Praluent(Alirocumab) Injection 7/9/2015 9:24:23 AM